OXCARBAZEPINE VS PHENYTOIN IN THE TREATMENT OF SEIZURES IN PATIENTS WITH BRAIN TUMORS UNDERGOING NEUROSURGICAL PROCEDURES

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2007
INTERVENTION: Trade Name: TOLEP*50CPR DIV 600MG Pharmaceutical Form: Tablet INN or Proposed INN: Oxcarbazepine CAS Number: 28721‐07‐5 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 600‐ Trade Name: DINTOINA*30CPR 100MG Pharmaceutical Form: Tablet INN or Proposed INN: Phenytoin CAS Number: 630‐93‐3 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100‐ CONDITION: SEIIZURES IN PATIENTS WITH BRAIN TUMORS ; MedDRA version: 9.1 Level: LLT Classification code 10053551 Term: Intractable epilepsy PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Epistemonikos ID: f7e18098cdbe0e1095b4dac0d262cf049e30493c
First added on: Aug 21, 2024